MENU

CDXS Stock Tickeron detected bullish Stock Pattern: Head-and-Shoulders Bottom CDXS on September 29, 2025, netting in a 12.08% gain over 1 week

A.I.dvisor
at Tickeron.com
Loading...
+12.08% Gain from a Successful pattern Head-and-Shoulders Bottom
CDXS - Codexis
Tickeron
Ticker: CDXS
Company: Codexis
Gain: +12.08%
Confirmed: 09/29/25
Succeeded: 10/06/25
Total length: 11 days
On September 25, 2025, A.I.dvisor detected a Head-and-Shoulders Bottom Pattern (Bullish) for Codexis (CDXS, $2.40). On September 29, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $2.66. 7 days later, on October 06, 2025, CDXS reached the target price resulting in a +1 for traders who took a long position in the stock.

CDXS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for CDXS turned positive on September 18, 2025. Looking at past instances where CDXS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CDXS's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 01, 2025. You may want to consider a long position or call options on CDXS as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CDXS advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

CDXS moved below its 50-day moving average on October 07, 2025 date and that indicates a change from an upward trend to a downward trend.

CDXS broke above its upper Bollinger Band on October 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CDXS entered a downward trend on September 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.365) is normal, around the industry mean (23.421). P/E Ratio (0.000) is within average values for comparable stocks, (54.441). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.237). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (3.779) is also within normal values, averaging (342.085).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CDXS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CDXS showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of biocatalytic chemical processes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
200 Penobscot Drive
Phone
+1 650 421-8100
Employees
174
Web
https://www.codexis.com